Fibromyalgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Female patients diagnosed with Fibromyalgia based on the 1990 criteria of the American College of Rheumatology, pain on the numerical scale of pain between 3 and 8 cm; age between 18 and 65 years and everyone should have agreed to participate in the research by signing the consent form.
Exclusion criteria
Exclusion criteria: Inflammatory rheumatic diseases; neurological diseases; patients who were undergoing psychiatric treatment; practice of physical activity started or changed in the last three months; medication started or changed in the last three months; patients with uncontrolled cardiorespiratory and cardiovascular diseases or any condition that contraindicates exercise; patients with uncontrolled diabetes mellitus and other musculoskeletal diseases that prevented the practice of the method.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease in pain, verified by the numerical pain scale, from the observation of an improvement of at least 20% in the measurements over time. | — |
Secondary
| Measure | Time frame |
|---|---|
| Increase in quality of life, as verified by the Fibromyalgia Impact Questionnaire (FIQ), based on the observation of an improvement of at least 20% in the measurements over time.;Decrease in catastrophizing, verified by questionnaire of hair avoidance of the medium, from the improvement of at least 20% in the measurements over time.;Decrease in anxiety and depression, verified by Beck's depression inventory, from the observation of an improvement of at least 20% in the measurements over time.;Increase in the general quality of life, verified by the SF-36 questionnaire, from the observation of an improvement of at least 20% in the measurements over time.;Increase in functional capacity, verified by the six-minute walk test, from the observation of an improvement of at least 20% in the measurements over time.;Decrease in kinesiophobia, verified by the kinesiophobia scale, from the observation of an improvement of at least 20% in the measurements over time.;Increase in patient satisfaction with the treatment, verified by the Likert scale, from the observation of an improvement of at least 20% in the measurements over time. ;Decrease in the consumption of painkillers, verified by counting the number of painkillers consumed, from the observation of an improvement of at least 20% in the measurements over time. | — |
Countries
Brazil
Contacts
Universidade Federal de São Paulo